{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:44:54Z","timestamp":1762145094761,"version":"3.40.5"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish MNiSW","award":["N N401 647340"],"award-info":[{"award-number":["N N401 647340"]}]},{"name":"the Institute of Pharmacology"},{"DOI":"10.13039\/501100004382","name":"Polish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bbr.2015.01.043","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T21:39:06Z","timestamp":1422913146000},"page":"203-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: Comparison to the classical neurotoxin 6-OHDA"],"prefix":"10.1016","volume":"283","author":[{"given":"Jolanta","family":"Konieczny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinga","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2015.01.043_bib0425","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg","volume":"40","author":"Ciechanover","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2015.01.043_bib0430","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbr.2015.01.043_bib0435","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klein Wochenschr"},{"key":"10.1016\/j.bbr.2015.01.043_bib0440","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2015.01.043_bib0445","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2015.01.043_bib0450","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2015.01.043_bib0455","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-4328(89)80121-4","article-title":"Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage","volume":"33","author":"Luthman","year":"1989","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","article-title":"Mechanisms of action of 6-hydroxydopamine","volume":"24","author":"Sachs","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0465","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.7732382","article-title":"Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin","volume":"268","author":"Fenteany","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbr.2015.01.043_bib0470","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12640-014-9477-9","article-title":"Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's Disease","volume":"26","author":"Konieczny","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0475","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","article-title":"Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures","volume":"81","author":"McNaught","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.01.043_bib0480","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.expneurol.2006.07.010","article-title":"Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic cultures","volume":"202","author":"Reaney","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0485","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.01.043_bib0490","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0495","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","article-title":"Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats","volume":"58","author":"Lorenc-Koci","year":"2011","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2015.01.043_bib0500","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2013.03.021","article-title":"Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry","volume":"247","author":"Mackey","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0505","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.01.024","article-title":"Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition","volume":"380","author":"Miwa","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2015.01.043_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-1","article-title":"Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease","volume":"11","author":"Vernon","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0515","doi-asserted-by":"crossref","first-page":"e17269","DOI":"10.1371\/journal.pone.0017269","article-title":"Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease","volume":"6","author":"Vernon","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbr.2015.01.043_bib0520","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","article-title":"Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease","volume":"115","author":"Xie","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.01.043_bib0525","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2013.12.019","article-title":"Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra","volume":"261","author":"Konieczny","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0530","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","article-title":"Proteasome inhibition causes nigral degeneration with inclusion bodies in rats","volume":"13","author":"McNaught","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2015.01.043_bib0535","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000202972","article-title":"Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition","volume":"87","author":"Niu","year":"2009","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.bbr.2015.01.043_bib0540","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00429-013-0669-5","article-title":"An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease","volume":"220","author":"Pienaar","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.bbr.2015.01.043_bib0545","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.bbr.2015.01.043_bib0550","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","article-title":"Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons","volume":"36","author":"Petrucelli","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2015.01.043_bib0555","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-4159.2005.03124.x","article-title":"Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition","volume":"93","author":"Rideout","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.01.043_bib0560","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0006-8993(02)04030-1","article-title":"Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons","volume":"964","author":"Kikuchi","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0565","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","article-title":"Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy","volume":"84","author":"Hirsch","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2015.01.043_bib0570","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(79)90983-1","article-title":"Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat","volume":"176","author":"Di Chiara","year":"1979","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bbr.2015.01.043_bib0580","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(92)90429-6","article-title":"The regional, cellular and subcellular localization of GABAA\/benzodiazepine receptors in the substantia nigra of the rat","volume":"50","author":"Nicholson","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.01.043_bib0585","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0306-4522(99)00413-3","article-title":"Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus","volume":"95","author":"Chadha","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.01.043_bib0590","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1471-4159.1985.tb07205.x","article-title":"Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle","volume":"45","author":"Pan","year":"1985","journal-title":"J Neurochem"},{"year":"1986","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","key":"10.1016\/j.bbr.2015.01.043_bib0595"},{"key":"10.1016\/j.bbr.2015.01.043_bib0600","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2012.08.015","article-title":"6-OHDA injections into A8\u2013A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats","volume":"1477","author":"Kolasiewicz","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0605","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2013.10.011","article-title":"Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine","volume":"1541","author":"Czarnecka","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0610","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2818.1984.tb02501.x","article-title":"The unbiased estimation of number and sizes of arbitrary particles using the disector","volume":"134","author":"Sterio","year":"1984","journal-title":"J Microsc"},{"key":"10.1016\/j.bbr.2015.01.043_bib0615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","article-title":"The efficiency of systematic sampling in stereology \u2013 reconsidered","volume":"193","author":"Gundersen","year":"1999","journal-title":"J Microsc"},{"key":"10.1016\/j.bbr.2015.01.043_bib0620","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-9861(19960617)370:1<11::AID-CNE2>3.0.CO;2-O","article-title":"Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method","volume":"370","author":"West","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0625","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuroscience.2005.06.086","article-title":"Estimators of the precision of stereological estimates: an example based on the CA1 pyramidal cell layer of rats","volume":"136","author":"Slomianka","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.01.043_bib0630","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1734-1140(11)70541-2","article-title":"Time course of changes in rotational behavior and DA metabolism in rats lesioned unilaterally with selective proteasome inhibitor lactacystin","volume":"63","author":"Konieczny","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bbr.2015.01.043_bib0635","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.30.12.1326","article-title":"Is the mesocortical dopaminergic system involved in Parkinson disease?","volume":"30","author":"Javoy-Agid","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2015.01.043_bib0640","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuroscience.2008.01.046","article-title":"Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat","volume":"152","author":"Nair-Roberts","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.01.043_bib0645","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1523\/JNEUROSCI.07-12-03915.1987","article-title":"The neostriatal mosaic. II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems","volume":"7","author":"Gerfen","year":"1987","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0650","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-3940(86)90377-0","article-title":"Cholinergic neurons in the rat substantia nigra","volume":"63","author":"Gould","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2015.01.043_bib0655","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cne.902810306","article-title":"Cholinergic somata and terminals in the rat substantia nigra: an immunocytochemical study with optical and electron microscopic techniques","volume":"281","author":"Mart\u00ednez-Murillo","year":"1989","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0660","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2013.06.008","article-title":"A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats","volume":"248","author":"Pienaar","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0665","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.freeradbiomed.2010.07.014","article-title":"Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins","volume":"49","author":"Dasuri","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bbr.2015.01.043_bib0670","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1471-4159.2004.02802.x","article-title":"Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures","volume":"91","author":"Ding","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.01.043_bib0675","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1523\/JNEUROSCI.4393-08.2008","article-title":"Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons","volume":"28","author":"Tydlacka","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0680","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/glia.20870","article-title":"The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition","volume":"57","author":"Goldbaum","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.bbr.2015.01.043_bib0685","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.bbadis.2013.07.002","article-title":"Implications for oxidative stress and astrocytes following 26S proteasomal depletion in mouse forebrain neurones","volume":"1832","author":"Elkharaz","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbr.2015.01.043_bib0690","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnmol.2014.00073","article-title":"The ubiquitin proteasome system in glia and its role in neurodegenerative diseases","volume":"7","author":"Jansen","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0695","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11064-008-9830-6","article-title":"Lactacystin stimulates stellation of cultured rat cortical astrocytes","volume":"34","author":"Ren","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0700","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mds.20877","article-title":"Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations","volume":"21","author":"Paviour","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2015.01.043_bib0705","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00702-002-0785-5","article-title":"Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD","volume":"110","author":"Yekhlef","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2015.01.043_bib0710","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-5347(25)00257-5","article-title":"On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat","volume":"241","author":"Harik","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2015.01.043_bib0715","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245141","article-title":"Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+","volume":"74","author":"Sun","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2015.01.043_bib0720","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1995.64020794.x","article-title":"Neurotoxic effect of intranigral injection of 1-methyl-4-phenylpyridinium on GABA-containing neurons and its relation to circling behavior","volume":"64","author":"Jasso-L\u00f3pez","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.01.043_bib0725","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.05.051","article-title":"Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion","volume":"1051","author":"Sindhu","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0730","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6123(06)60009-5","article-title":"The pars reticulata of the substantia nigra: a window to basal ganglia output","volume":"160","author":"Deniau","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0735","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(94)00607-7","article-title":"GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease","volume":"66","author":"Nicholson","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.01.043_bib0740","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s002130100908","article-title":"Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies","volume":"159","author":"Trevitt","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2015.01.043_bib0745","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0304-3940(77)90183-5","article-title":"Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra","volume":"4","author":"Scheel-Kr\u00fcger","year":"1977","journal-title":"Neurosci Lett"},{"issue":"Suppl.","key":"10.1016\/j.bbr.2015.01.043_bib0750","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1471-1931(00)00028-8","article-title":"Pathophysiology of the basal ganglia in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0755","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.03-06-01189.1983","article-title":"Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography","volume":"3","author":"Pan","year":"1983","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0760","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00431958","article-title":"GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters","volume":"62","author":"Arnt","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2015.01.043_bib0765","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00518191","article-title":"Enhanced muscimol-induced behavioral responses after 6-OHDA lesions: relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats","volume":"91","author":"Breese","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2015.01.043_bib0770","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00236638","article-title":"Lesions of the globus pallidus, entopeduncular nucleus and substantia nigra alter dopamine mediated circling behaviour","volume":"52","author":"Dewar","year":"1983","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0775","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00498985","article-title":"Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons","volume":"306","author":"Di Chiara","year":"1979","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0780","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2015.01.043_bib0785","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0404.1986.tb03249.x","article-title":"Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration","volume":"73","author":"Araki","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bbr.2015.01.043_bib0790","first-page":"427","article-title":"CSF GABA levels in Parkinson's disease","volume":"40","author":"de Jong","year":"1984","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0795","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archneur.1982.00510190009002","article-title":"Low CSF gamma-aminobutyric acid levels in Parkinson's disease. Effect of levodopa and carbidopa","volume":"39","author":"Manyam","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0800","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(77)90540-6","article-title":"Distribution of high affinity sodium-independent [3H] gamma-aminobutyric acid binding in the human brain: alterations in Parkinson's disease","volume":"127","author":"Lloyd","year":"1977","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0805","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1750-3639.2010.00396.x","article-title":"Neurosteroid biosynthetic pathway changes in substantia nigra and caudate nucleus in Parkinson's disease","volume":"20","author":"Luchetti","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0810","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1254\/jjp.48.331","article-title":"GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease","volume":"48","author":"Nishino","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bbr.2015.01.043_bib0815","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/0024-3205(78)90575-1","article-title":"GABA receptor binding in the parkinsonian brain","volume":"22","author":"Rinne","year":"1978","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2015.01.043_bib0820","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/neur.1996.0007","article-title":"Substantia nigra pars reticulata neurons in Parkinson's disease","volume":"5","author":"Hardman","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.bbr.2015.01.043_bib0825","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mds.10343","article-title":"Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications","volume":"18","author":"Calon","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2015.01.043_bib0830","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0197-0186(99)00064-9","article-title":"Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)\/benzodiazepine receptor complex and GABA content","volume":"35","author":"Calon","year":"1999","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2015.01.043_bib0835","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(95)00229-J","article-title":"Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex","volume":"680","author":"Calon","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.01.043_bib0840","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(90)90762-Z","article-title":"The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography","volume":"531","author":"Robertson","year":"1990","journal-title":"Brain Res"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T06:02:54Z","timestamp":1747548174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432815000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":84,"alternative-id":["S0166432815000601"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2015.01.043","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: Comparison to the classical neurotoxin 6-OHDA","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2015.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}